Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells

  • Mucci S
  • Herrera M
  • Barreto G
  • et al.
5Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.

Cite

CITATION STYLE

APA

Mucci, S., Herrera, M. I., Barreto, G. E., Kolliker-Frers, R., & Capani, F. (2017). Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells. Current Pharmaceutical Design, 23(26). https://doi.org/10.2174/1381612823666170727145422

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free